pembrolizumab
merck
['melsm']
 it's a money shot of the primary endpoint ... not so much of me #s1801 #neoadjuvant #melsm #esmo22
SWOG Melanoma Chair, Med Onc at MD Anderson Cancer Center.  Tweets are my own.